Results 141 to 150 of about 13,459 (185)

Oncolytic Virotherapy in Colorectal Cancer: Mechanistic Insights, Enhancer Strategies, and Translational Combinations. [PDF]

Cells
Salameh H, Naseem N, Chattha MA, Ramesh J, Ramy H, Cizkova D, Kubatka P, Büsselberg D.   +7 more
europepmc   +1 more source

Dual-cytokine-armed oncolytic HSV for enhanced tumor immunotherapy. [PDF]

Mol Ther Oncol
Dhital R, Pereira MSF.
europepmc   +1 more source

Multimodal Key Anti-Oncolytic Therapeutics Are Effective In Cancer Treatment? [PDF]

Int J Nanomedicine
Ye L, Gao M, Chen Y, Zhu Y, Wang J, Wang Z.   +5 more
europepmc   +1 more source

Enhancing oncolytic virotherapy with a tri-specific T-cell engager targeting CD3ε, EpCaM, and 4-1BB: preclinical evaluation and implications for cancer immunotherapy. [PDF]

BMC Med
Dong Z, Zhang H, Zhang H, Bai L, Guo Q, Robinson G, Elalfy A, Liu T, Aimaiti M, Xia X, Zuo S, Zhang Z.   +11 more
europepmc   +1 more source

Novel immune checkpoint inhibitor FilC/PD-1 recombinant vaccinia virus inhibits hepatocellular carcinoma. [PDF]

Front Med (Lausanne)
Luo Y, Hu Z, Du G, Xin W, Wang M.
europepmc   +1 more source

Extended Survival in a Dog with Primary Bone Hemangiosarcoma Following Treatment with Neoadjuvant Oncolytic Virotherapy and Standard of Care. [PDF]

Vet Sci
Labé C, Chehadeh A, Winter A, Pracht S, Stuebner KM, Lewellen M, Eskander B, O'Sullivan MG, Tabaran AF, Ober C, Henson MS, Seelig D, Russell SJ, Modiano JF, Naik S, Makielski KM.   +15 more
europepmc   +1 more source

Addition of oncolytic virotherapy to clinical isolated limb perfusion for melanoma and sarcoma activates antitumor immunity. [PDF]

J Immunother Cancer
Hayes AJ, Davies EJ, Wilkinson M, Smith HG, Nenclares P, Lund T, Larkeryd A, Appleton E, Patin EC, Pedersen M, Rullan A, Mohamed HS, Aronson L, Murphy J, Grove L, Mansfield D, Mclaughlin M, Harrington KJ, Melcher A.   +18 more
europepmc   +1 more source

<i>Vaccinia Virus</i> Converts Microglia into Potent Oncolytic Agent for Glioblastoma and Neuroblastoma. [PDF]

Cells
Ekrami E, Ghanbari P, Othman EM, Szalay AA.   +3 more
europepmc   +1 more source

Correction: Experimental models for developing oncolytic virotherapy for metastatic prostate cancer. [PDF]

Front Immunol
Chen YC, Figueiredo ML.
europepmc   +1 more source

Oncolytic virotherapy and tumor microenvironment modulation. [PDF]

Clin Exp Med
Rivera-Orellana S, Bautista J, Palacios-Zavala D, Ojeda-Mosquera S, Altamirano-Colina A, Alcocer-Veintimilla M, Parrales-Rosales G, Izquierdo-Condoy JS, Vásconez-González J, Ortiz-Prado E, Muslin C, López-Cortés A.   +11 more
europepmc   +1 more source